Wiesel F A, Alfredsson G, Ehrnebo M, Sedvall G
Psychopharmacology (Berl). 1982;76(1):44-7. doi: 10.1007/BF00430753.
Sulpiride (100 mg) was administered intravenously and orally to healthy human subjects. Serum concentrations of sulpiride and prolactin were followed for 36 h. Both routes of drug administration resulted in a pronounced and sustained increase in serum prolactin concentration. The prolactin response was positively correlated to the prolactin baseline value. The concentrations of prolactin remained at an elevated plateau for 9--36 h after drug treatment despite low drug concentrations. The level of this plateau was directly related to the normal circadian secretion of prolactin. The sustained prolactin elevation may be due to high affinity and strong binding of the compound to the regulating receptors or the formation of an active sulpiride metabolite. Prolactin and sulpiride concentrations were significantly correlated during the initial phase after intravenous sulpiride. Following intravenous and oral sulpiride the area under the concentration-time curve (AUC) for prolactin was similar despite a considerable difference in the sulpiride concentration.
对健康人体受试者静脉注射和口服舒必利(100毫克)。对舒必利和催乳素的血清浓度进行了36小时的跟踪监测。两种给药途径均导致血清催乳素浓度显著且持续升高。催乳素反应与催乳素基线值呈正相关。尽管药物浓度较低,但药物治疗后催乳素浓度在9 - 36小时内保持在升高的平台期。该平台期水平与催乳素的正常昼夜分泌直接相关。催乳素的持续升高可能是由于该化合物对调节受体的高亲和力和强结合力,或者是形成了一种活性舒必利代谢物。静脉注射舒必利后的初始阶段,催乳素和舒必利浓度显著相关。静脉注射和口服舒必利后,尽管舒必利浓度存在相当大的差异,但催乳素的浓度-时间曲线下面积(AUC)相似。